Saturday, July 12, 2025

Latest

Valens: Canaccord Lowers Price Target To $3.75

Earlier this month, The Valens Company (TSX: VLNS) reported their fiscal third-quarter financial results. The company reported net revenue of $20.99 million, up from the $18.76 million reported last quarter. Gross margins were 26.8% for the quarter compared to 22% last quarter, while adjusted EBITDA came in lower than last quarter at negative $6.18 million. The company reported a net loss of $12.8 million. Valens saw its SKU count go from 75 at the end of the first fiscal quarter to now 181 at the end of this quarter.

The Valens Company currently has 9 analysts covering the stock with an average 12-month price target of C$3.92, or 89% upside. Out of the 9 analysts, 1 has a strong buy rating, 7 have buys and 1 analyst has a hold rating. The street high sits at C$5.25 from Stifel-GMP, while the lowest comes in at C$2.50.

In a note, Canaccord Genuity lowered their price target to C$3.75 from $4.25 and speculative buy rating saying that after their first run-through the company is now focusing on margins. For the quarter, Canaccord forecasted revenue to be C$22.5 million.

Canaccord notes that this quarter included partial sales from Green Roads which accounted for C$4.7 million, so if you would back that out then sales would have declined by 12%. They write that this decline would be attributed to the company “transitioning away from smaller, underperforming B2B partners in favour of building deeper relationships with larger LPs.”

Onto gross margins, the company saw a 4.8% increase in gross margins, which can be partially attributed to the Green Roads inclusion. Canaccord writes, “Having now achieved critical mass for its SKU listings, VLNS plans to shift focus to driving margin expansion through automation, volume growth, and operational efficiencies.”


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Ayr Wellness: Canaccord Reiterates $70 Price Target Following Earnings

Earlier this week, Ayr Wellness (CSE: AYR.a) reported their first-quarter earnings. The company reported revenues...

Friday, May 28, 2021, 04:02:00 PM

Cineplex: BMO Reiterates Targets Despite Earnings Missing Consensus

Cineplex Inc. (TSX: CGX) reported its second quarter financial results last week. The company announced...

Monday, August 15, 2022, 12:24:00 PM

Tesla: Canaccord Doubles Price Target To $1,071

On Monday, one of the more bearish Tesla Inc. (NASDAQ: TSLA) analysts flipped bullish, and...

Tuesday, April 13, 2021, 11:41:00 AM

BMO Reiterates $21 Price Target On Osisko Gold Royalties

Last week, Osisko Gold Royalties (TSX: OR) announced their preliminary second quarter deliveries and gave...

Thursday, July 22, 2021, 01:48:00 PM

BMO Lowers Microsoft’s Price Target Due To US Dollar Strength

As earnings season is fast approaching, analysts are coming out with their previews, and one...

Tuesday, July 26, 2022, 02:18:00 PM